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Differential Requirements for Vav Proteins in DAP10and ITAM-mediated NK Cell Cytotoxicity
Marina Cella,1 Keiko Fujikawa,1,3 Ilaria Tassi,1 Sunjin Kim,1,2 Kevin Latinis,1,2
Shinzo Nishi,3 Wayne Yokoyama,1,2 Marco Colonna,1 and Wojciech Swat1
1Department

of Pathology and Immunology and 2Department of Medicine and Howard Hughes Medical
Institute,Washington University School of Medicine, St. Louis, MO 63130
3Department of Biochemistry, Hokkaido University Graduate School of Medicine, 060-8638 Sapporo, Japan

Natural killer (NK) cells express multiple activating receptors that initiate signaling cascades
through DAP10- or immunoreceptor tyrosine-based activation motif–containing adapters, including DAP12 and FcR. Among downstream signaling mediators, the guanine nucleotide exchange
factor Vav1 carries out a key role in activation. However, whether Vav1 regulates only some or
all NK cell–activating pathways is matter of debate. It is also possible that two other Vav family
molecules, Vav2 and Vav3, are involved in NK cell activation. Here, we examine the relative
contribution of each of these exchange factors to NK cell–mediated cytotoxicity using mice
lacking one, two, or all three Vav proteins. We found that Vav1 deficiency is sufficient to disrupt
DAP10-mediated cytotoxicity, whereas lack of Vav2 and Vav3 profoundly impairs FcR- and
DAP12-mediated cytotoxicity. Our results provide evidence that these three Vav proteins function
specifically in distinct pathways that trigger NK cell cytotoxicity.
Key words: DAP12 • NKG2D • adapters • GEF • FcR

Introduction
NK cells express multiple activating receptors with diverse
structures and specificities. In mice, prototypic receptors
include NKG2D, Ly49D, Ly49H, and the low affinity receptor for IgG, FcRIIIa. NKG2D recognizes endogenous
MHC class I–related molecules including, the retinoic acid–
inducible proteins Rae1-, the minor histocompatibility
antigen H60, and the UL16-binding proteinlike transcript
(MULT; references 1, 2). These molecules are expressed at
high levels primarily in virally infected and tumor cells (1, 2).
Ly49D triggers killing of allogeneic bone marrow cells and
Chinese hamster ovary (CHO) cells by recognizing murine
and hamster class I molecules (3, 4). Ly49H mediates selective recognition of m157, a murine cytomegalovirus–
encoded class I–like molecule that is expressed on infected
cells (5, 6). FcRIIIa promotes lysis of IgG-coated target cells
by antibody-dependent, cell-mediated cytotoxicity (ADCC).
NKG2D, Ly49D, Ly49H, and FcRIIIa lack cytoplasmic
signaling elements and can deliver stimulatory signals only

by associating with transmembrane adaptor proteins. Ly49D
and Ly49H signal through DAP12 (also called KARAP),
whereas FcRIIIa associates with the  chain of Fc receptors (FcR) and CD3 (7, 8). DAP12, FcR, and CD3
contain immunoreceptor tyrosine-based activation motifs
(ITAMs) that are phosphorylated and function as docking
sites for Syk and ZAP70 protein tyrosine kinases (7, 8).
NKG2D includes two isoforms that differ in their cytoplasmic domains and associated adaptors (9, 10). NKG2D-long
(NKG2D-L) signals through DAP10, a unique adaptor containing a YxNM motif that recruits phosphatidylinositol3-kinase (PI-3K; reference 11) and Grb-2. NKG2D-short
(NKG2D-S) associates with both DAP10 and DAP12 (9, 10).
Syk, ZAP70, and PI-3K initiate signaling cascades that lead
to activation of mitogen-activated protein kinases (MEKs),
phospholipase C (PLC), Ca2 mobilization, secretion of
IFN-, and release of cytotoxic granules that contain perforin and granzymes (7, 8).
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Materials and Methods
Mice. Vav1ko, Vav2ko, Vav3ko, Vav2,3ko, Vav1,2,3ko, DAP10ko,
and DAP12ko mice have been described previously (10, 23).
RNase Protection Assay (RPA). Riboprobes included cDNA
fragments of murine Vav1 (nucleotide [nt] 664–862), Vav2 (nt
652–800), and Vav3 (nt 676–852). RPA was performed by standard techniques.
Cytotoxicity Assays. NK cells were purified from spleens with
DX5 microbeads (Miltenyi Biotec), cultured for different periods
of time in RPMI 1640 with 10% heat-inactivated FCS (Hyclone)
and 1,000 U/ml rIL-2 (Roche) and tested against target cells by
standard 51Cr release assay. Target cells used to assess natural cytotoxicity included YAC-1, CHO, RMAS, RMAS-Rae1  (10),
Baf3, and Baf3-m157 (6). ADCC was evaluated using EL-4 cells
coated with the anti-Thy1.2 antibody TIB-107 (American Type
Culture Collection). Cytotoxicity was blocked with antibodies
against Ly49D (4), Ly49H (6), or NKG2D (10). In some experiments, NK cells were pretreated for 20 min at 37 C with the
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MEK inhibitor PD98059 (Calbiochem) before the addition of
antibodies and 51Cr-labeled cells.
Biochemical Analysis. WT, DAP10ko, DAP12ko, Vav1ko, and
Vav1,2,3ko NK cells were cultured for different periods of time in
IL-2. After incubation with mAb HB-197 (Fc block; American
Type Culture Collection) for 15 min on ice to block Fc receptors, NK cells (4  106/sample) were treated with biotinylated
anti–mouse NKG2D (1 g/106 cells) for 15 min on ice followed
by streptavidin (1.51 g/106 cells) at 37C for 2 and 5 min. Alternatively, NK cells were conjugated at 37 C for 5 min with
CHO cells. NK cell lysates were analyzed by SDS-PAGE and
immunoblotting using antibodies against pERK1/2 (Thr202/
Tyr204) and ERK1/2 (New England Biolabs Inc.).
Online Supplemental Material. In Fig. S1, Vav1, 2, and 3 are
expressed in NK cells, but are not required for NK cell maturation. Fig. S2 shows NKG2D-mediated cytotoxicity in Vav1 ko
and DAP10ko NK cells. Fig. S3 depicts lysis of RMA-S/Rae1 
and YAC-1 cells by Vav1,2,3 ko and Vav2,3ko NK cells ex vivo
and early after IL-2 activation. In Fig. S4, Vav deficiency does
not affect conjugate formation between WT, Vav-deficient NK
cells, and target cells. Online supplemental material is available at
http://www.jem.org/cgi/content/full/jem.20031847/DC1.

Results and Discussion
Vav1, Vav2, and Vav3 Are Expressed in NK Cells, but Are
Not Required for NK Cell Maturation and Cell Surface Expression of Activating and Inhibitory Receptors. To determine which
vav genes are expressed in NK cells, we performed a quantitative RPA with riboprobes specific for individual Vav transcripts. All three vav genes were expressed in primary mouse
NK cells. Vav1 and Vav3 transcripts were the most abundant, whereas the vav2 gene was expressed at low levels
(Fig. S1 A, available at http://www.jem.org/cgi/content/
full/jem.20031847/DC1). Consistent with the results of RPA
analyses, Vav1 and Vav3 proteins were expressed at very
high levels in IL-2–cultured NK cells, whereas the Vav2
protein was less abundant (Fig. S1 B). NK cell development
is normal in mice lacking Vav1 (21). Despite severe defects
in the production of mature T and B lymphocytes in the
periphery (23), healthy Vav1,2,3ko mice (4–5 wk old) harbored normal NK cell numbers in the spleen, as did Vav1ko
mice (Fig. S1 C). In addition, Vav1,2,3ko and WT NK cells
expressed comparable levels of DX5, IL-2/15R (CD122),
NK1.1, NKG2D, Mac-1 (CD11b), and NKG2A on the
cell surface and similar percentages of the NK populations
expressed Ly49A, Ly49D, and Ly49H (Fig. S1 D and not
depicted). Thus, none of the Vav proteins appear to be essential for NK cell maturation or surface expression of activating or inhibitory NK cell receptors.
Vav1 Protein Is Not Necessary for FcR- and DAP12-mediated Cytotoxicity. To determine the function of Vav1 protein in ITAM-dependent signaling, we examined ADCC as
well as Ly49H/DAP12- and Ly49D/DAP12-mediated cytotoxicity in Vav1ko and WT mice. Vav1ko and WT NK cells
killed EL-4 cells coated with an anti-Thy1.2 antibody
equally well (Fig. 1 A). Similarly, Vav1ko NK cells killed Baf3
cells expressing m157 (Baf3-m157; references 5, 6), but not
Baf3 cells transfected with a control plasmid (Fig. 1 B). Fi-
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Vav proteins are critical signaling mediators that connect
protein tyrosine and inositol kinases with effector responses
in NK cells (12, 13). Vav proteins include three closely
related guanine nucleotide exchange factors (Vav1, Vav2,
and Vav3) that activate small GTP-binding proteins belonging to the Rho-Rac/Cdc42 family, including Rac1,
RhoA, and RhoG (14). Rac1 sequentially activates p21activated kinase 1 (PAK1), MEK, and extracellular signalregulated kinase (ERK)1/2. In addition, Vav proteins perform
adaptor functions by binding the Src homology 2 domaincontaining leukocyte phosphoprotein (SLP)76, which is
part of a complex including PLC and the linker for activation of T cells (LAT; references 14, 15). In vitro studies
demonstrated that Vav1, Vav2, and Rac1 are activated in
human NK cells after challenge with tumor cells (16, 17)
or engagement of FcRIIIa (17), integrins (18, 19), and
NKG2D (20) with cognate ligands or specific antibodies.
Moreover, blocking Vav1 or Rac1 function using antisense
oligonucleotides for Vav1 or a dominant-negative form of
Rac1 inhibits NK cell adhesion to target cells, cytotoxicity
and secretion of IFN- (16, 17, 20). Consistent with these
results, in vivo studies demonstrated that Vav1 deficiency
reduces “natural” cytotoxicity, the ability of NK cells to
lyse various tumor cells (21, 22). However, the impact of
Vav1 deficiency on ADCC was controversial (21, 22) and
INF- secretion was not affected in Vav1ko mice (21), suggesting that Vav1 may not regulate all NK cell effector
functions. The possible involvement of other Vav family
members in NK cell activation has not been addressed in
vivo.
Here, we investigate the requirement for Vav proteins in
cytotoxicity mediated by several different activating NK
cell receptors using mice lacking one, two, or three Vav
proteins. We show that lack of Vav1 primarily impairs the
NKG2D–DAP10 cytolytic pathway, whereas lack of Vav2
and Vav3 reduces cytotoxicity triggered by receptors that
signal through ITAM-containing adapters. Our findings
demonstrate an unexpected specialization of Vav proteins
in regulating different cytotoxic pathways.

Published September 13, 2004

nally, Vav1-deficient NK cells efficiently lysed CHO cells in
a Ly49D-mediated manner (Fig. 1 C). We conclude that
FcRIIIA/FcR-, Ly49H/DAP12-, and Ly49D/DAP12mediated cytotoxicity are largely Vav1 independent. Because
the DAP12 and FcR adapters recruit signaling mediators
through cytoplasmic ITAMs, our results indicate that ITAMmediated cytotoxicity in NK cells does not require Vav1.
Vav1 Protein Is Essential for DAP10-mediated Cytotoxicity.
NK cells express two isoforms of NKG2D: NKG2D-L and
NKG2D-S (9). NKG2D-L signals through DAP10, whereas
NKG2D-S signals through both DAP12 and DAP10. The
relative proportion of NKG2D-L and NKG2D-S in NK cells
varies during IL-2 activation. NK cells isolated ex vivo predominantly express NKG2D-L (9), although some NKG2D-S
is also present (unpublished data). Early after IL-2 activation (6–10 d), NK cells up-regulate NKG2D-S. After prolonged culture with IL-2 (10–30 d), NKG2D-S expression
819
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Figure 1. ITAM-dependent cytotoxicity in Vav1ko mice. Cytotoxicity
of Vav1ko NK cells was tested against the following: (A) EL-4 cells with or
without an anti-Thy1.2 mAb, (B) Baf-3-m157 and mock-transfected Baf-3
with or without a blocking mAb against Ly49H, and (C) CHO cells with
or without a blocking anti-Ly49D mAb. NK cells were cultured in IL-2
for 10–15 d, contained 98% NK1.1/CD3 cells. Vav1ko and WT NK
cells exhibited comparable percentages of Ly49H and Ly49D cells.

decreases and NKG2D-L again becomes predominant (9,
10). To determine the function of Vav1 in NKG2D/
DAP12- and NKG2D/DAP10-mediated cytotoxicity, we
compared cytotoxicity of Vav1ko and WT NK cells at
different time points during culture with IL-2. Target cells
included RMAS transfectants expressing Rae1 (RMASRae1), control RMAS transfectants, and YAC-1 cells, which
express NKG2D ligands and, hence, are lysed to some extent
in an NKG2D-dependent fashion (1). All experiments were
performed with or without a mAb against NKG2D to precisely define the proportion of target cell lysis mediated by
NKG2D. When evaluated for NKG2D-mediated lysis of
RMAS-Rae1, Vav1ko (day 0) were significantly less efficient than WT NK cells (Fig. 2 A). This difference was less
pronounced when Vav1ko were tested during culture with
IL-2 (days 6–12), but again became substantial after extended
culture (days 12–30; Fig. 2 A). NKG2D-mediated lysis of
YAC-1 was also affected by the lack of Vav1 (Fig. 2 B). The
severity of this deficit varied in a temporal pattern similar to
that observed for lysis of RMAS-Rae1, but was less pronounced, especially at day 0. We speculate that the few
NKG2D–DAP12 receptor complexes present in fresh NK
cells may be sufficient to trigger YAC-1 killing or may synergize with a yet unknown receptor mediating NKG2Dindependent lysis of YAC-1. In summary, the IL-2/timedependent deficit of RMAS-Rae1 and YAC-1 lysis caused
by Vav1 deficiency precisely mirrored the prevalence of
NKG2D-L/DAP10 signaling and paralleled that previously
observed in DAP10-deficient NK cells (Fig. S2, available at
http://www.jem.org/cgi/content/full/jem.20031847/DC1,
and reference 10). Therefore, we conclude that the NKG2D–
DAP10 pathway is largely Vav1 dependent.
Vav2 and Vav3 Proteins Are Required for FcR- and
DAP12-mediated Signaling. Vav2 is expressed in human
NK cells and plays a central role in NK cell–mediated cytotoxicity (24). In addition, NK cells express Vav3 (Fig. S1, A
and B). Thus, Vav1 may not be required for ITAM signaling
due to either preferential use of Vav2 and/or Vav3 in this
pathway or simple redundancy of the Vav proteins. To test
these hypotheses, we analyzed the impact of individual and
combined Vav1, Vav2, and Vav3 deficiencies on NK cell–
mediated cytotoxicity. Lack of Vav2 or Vav3 alone did not
significantly affect FcR-, DAP12-, or DAP10-mediated
killing at any time point (unpublished data). In contrast, lack
of all Vav proteins completely abrogated ADCC (Fig. 3 A)
and severely reduced lysis of Baf3-m157 (Fig. 3 B). However, Vav1,2,3ko NK cells were able to partially lyse Baf3m157 in a Ly49H-mediated manner at high E:T ratios (15–
20%). In addition, Ly49D-mediated lysis of CHO cells by
Vav1,2,3ko NK cells remained surprisingly intact (Fig. 3 C).
Lack of all three Vav proteins caused a marked reduction in
NKG2D-mediated lysis of RMAS-Rae1 and YAC-1 (Fig.
S3, A and B, available at http://www.jem.org/cgi/content/
full/jem.20031847/DC1). This defect was more profound
than that observed in Vav1ko mice and was evident in resting
as well as in IL-2–activated NK cells at any time during culture. We conclude that lack of all three Vav isoforms results
in a more substantial defect in NK cell–mediated cytotoxic-
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ity than does Vav1 deficiency alone and affects both DAP10mediated and ITAM-dependent cytotoxicity. The unexpected ability of Vav1,2,3ko NK cells to lyse CHO cells in a
Ly49D-mediated manner may suggest that Ly49D/DAP12
signaling is Vav independent. Alternatively, NK cell receptors for CHO cells may include one or more as yet unidentified Vav-independent receptors in addition to Ly49D. These
receptors may synergize with Ly49D or provide costimulation to Ly49D, allowing Ly49D signals to reach the threshold required for cytotoxicity.
To determine whether Vav2 and Vav3 proteins are preferentially used for ITAM signaling or Vav proteins are redundant, we tested FcR- and DAP12-mediated killing in
Vav2/3 double deficient mice. Vav2,3ko NK cells completely

lacked the capacity to carry out ADCC (Fig. 3 D) and had an
obvious defect in Ly49H-mediated killing (Fig. 3 E). Lysis of
RMAS-Rae1 (Fig. S3 C) and YAC-1 cells (Fig. S3 D) by
Vav2,3ko NK cells isolated ex vivo or cultured with IL-2
(short or long periods of time) was variably reduced, probably
due to conserved NKG2D/DAP10-mediated signaling and
dependent on the relative expression of NKG2D-L/NKG2D-S
isoforms in the different NK cell populations tested. We
conclude that Vav2/Vav3 and Vav1 are not redundant and
that Vav2 and Vav3 proteins specialize in ITAM signaling.
Vav Deficiency Disrupts ERK1/2 Activation Triggered by the
DAP10 and DAP12 Pathways. ERK1/2 activation is critical for promoting NK cell–mediated cytotoxicity (12). Because lack of Vav proteins impairs DAP10- and DAP12-

Figure 3. ADCC, Ly49H-, and Ly49D-dependent cytotoxicity in Vav1,2,3ko and Vav2,3ko NK cells. Cytotoxicity of Vav1,2,3ko (A and B) and
Vav2,3ko (D and E) was tested against EL-4 cells with or without an anti-Thy1.2 mAb as well as Baf-3-m157 and Baf-3. Cytotoxicity of Vav1,2,3ko was
also tested against CHO cells with and without a blocking anti-Ly49D antibody. ADCC was abrogated in both Vav1,2,3ko and Vav2,3ko NK cells;
Ly49H-dependent killing was severely impaired, whereas Ly49D-mediated CHO killing was considerably conserved (C). NK cells were cultured in IL-2
for 10–15 d. In the CHO killing experiment, Ly49D cells represented 35% of WT and 25% of Vav1,2,3ko NK cell cultures.
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Figure 2. NKG2D-dependent cytotoxicity in Vav1ko mice. Cytolitic activity of Vav1ko NK cells against RMA-S, RMA-S/Rae1 (A), and YAC-1
(B) in the presence of a blocking anti-NKG2D mAb or control mAb. Effector cells included freshly isolated NK cells (day 0) and NK cells cultured in IL-2 for 6,
15, and 30 d. Reduction of NKG2D-dependent cytotoxicity is particularly evident at day 0 (RMA-S-Rae1) and at day 30 (RMA-S-Rae1 and YAC-1).
Note that our RMA-S parental cell line is poorly killed by B6 NK cells although it expresses a low level of MHC class I. Different variants of RMA-S
may be more susceptible to NK cell–mediated lysis.

Published September 13, 2004

mediated cytotoxicity, we asked the following: (a) do the
DAP10 and DAP12 pathways trigger ERK1/2 activation;
(b) does the lack of Vav proteins impair DAP10- and/or
DAP12-mediated ERK1/2 activation; and (c) is blockade of
ERK1/2 activation sufficient to inhibit DAP10- and DAP12mediated cytotoxicity? To determine whether DAP10 and
DAP12 activate ERK1/2, we analyzed ERK1/2 phosphorylation in lysates from WT, DAP10ko, and DAP12ko NK
cells stimulated via NKG2D at day 7 of IL-2 culture. Both
NKG2D/DAP10 and NKG2D/DAP12 signaling mediated
ERK1/2 phosphorylation (Fig. 4 A). We also observed
marked ERK1/2 phosphorylation in WT NK cells conjugated with CHO cells, which was partially reduced in
DAP12ko NK cells. This provides further evidence that
recognition of CHO cells most likely involves receptors
other than Ly49D.
To determine whether Vav deficiency impairs DAP10and DAP12-mediated ERK1/2 activation, we cultured WT,
Vav1ko, and Vav1,2,3ko NK cells for 7 d in IL-2 to induce
expression of both NKG2D-L and NKG2D-S and stimulated them with an antibody specific for NKG2D. ERK1/2
phosphorylation was slightly reduced in Vav1ko NK cells and
completely abrogated in Vav1,2,3ko NK cells (Fig. 4 B). In
contrast, no defect of ERK1/2 activation was observed when
Vav1,2,3ko NK cells were conjugated with CHO cells (Fig. 4
B). Thus, there is a consistent correlation between Vavdependent changes in ERK1/2 activation and cytotoxicity.
Specifically, in Vav1,2,3ko NK cells, diminished cytotoxicity
821
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is paralleled by disruption of ERK1/2 activation. Conversely,
lysis of CHO cells by Vav1,2,3ko NK cells corresponds with
conserved ERK1/2 activation. The substantial preservation
of ERK1/2 phosphorylation in Vav1ko NK cells most likely
reflects ERK1/2 activation through the Vav2–Vav3 pathway, which mediates DAP12-mediated cytotoxicity.
To address the impact of impaired ERK1/2 activation on
DAP10- and ITAM-mediated cytotoxicity, we assessed the
effect of a pharmacological inhibitor of MEK on ADCC, lysis of Baf3-m157, and RMAS-Rae1 by WT NK cells,
which selectively express NKG2D-L/DAP10, at day 20 of
IL-2 culture. Remarkably, blockade of ERK1/2 dramatically
reduced NK cell–mediated cytotoxicity in all cases (Fig. 4
C). Identical results were obtained when we tested DAP10ko
and DAP12ko NK cells against RMAS-Rae1 in the presence of the ERK1/2 inhibitor (unpublished data). Together,
these results suggest that ERK1/2 may be important in linking DAP10–Vav1 and ITAM–Vav2,3 signaling pathways
with exocytosis of lytic granules. However, other downstream signaling mediators may be also implicated in DAP10/
Vav1 and ITAM–Vav2,3-mediated cytotoxicity. For example, Vav1 may promote the recruitment of PLC2, which
triggers Ca2 mobilization (20). In addition, Vav proteins
may cooperate with PI-3K, which initiates the PI-3K→
Rac1→PAK1→MEK→ERK cascade (13). Although Vav
proteins mediate signals that regulate cell adhesion and organization of actin cytoskeleton, conjugation of NK cells with
target cells was not affected by Vav deficiency, excluding a
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Figure 4. Effect of Vav deficiency on DAP10- and DAP12-dependent activation of ERK. (A) NKG2D–DAP10 and NKG2D–DAP12 pathways activate ERK1/2. WT, DAP10ko, and DAP12ko NK cells were incubated at 37C for the indicated times with anti-NKG2D mAb (left). WT and DAP12ko
NK cells were also conjugated with fixed CHO cells (right). NK cell lysates were analyzed by immunoblotting with antibody against active ERK1/2
(pERK1/2) and anti-ERK1/2. (B) Impact of Vav deficiency on activation of ERK1/2. WT, Vav1ko, and Vav1,2,3ko NK cells (left) were stimulated via
NKG2D as described in A. WT and Vav1,2,3ko NK cells were also conjugated with CHO cells (right). NK cell lysates were analyzed as indicated in A.
(C) MEK inhibitor PD98059 reduces NKG2D-, FcRIIIA-, and Ly49H-mediated cytotoxicity. IL-2–activated NK cells were preincubated at 37C for
30 min with PD98059 (50 M) or DMSO and tested for cytolytic activity against RMA-S, RMA-S/Rae1, EL-4 cells coated with anti-Thy1.2 mAb,
Baf-3, and Baf-3/m157.
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by concurrent activating signals transduced by Vav-independent receptors. In support of this model, we also observed that the defect of YAC-1 killing by Vav1,2,3ko NK
cells goes beyond that expected based on the impairment of
NKG2D–DAP10 and NKG2D–DAP12 signaling pathways
alone, suggesting that additional YAC-1–specific receptors
may integrate with NKG2D signaling to reach the threshold for the release of lytic granules.
The involvement of Vav1 in NKG2D/DAP10-mediated
signaling in mice shown in this work is in agreement with
the recent demonstration that NKG2D/DAP10 activates
Vav1 in human NK cells (20). It remains to be determined
how DAP10 selectively recruits Vav1, whereas ITAMcontaining adapters mainly signal through Vav2 and Vav3.
Although DAP10 recruits PI-3K, it has been shown that
activation of Vav1 through NKG2D/DAP10 occurs independently of PI-3K in human NK cells (20). Thus, DAP10
may recruit Vav1 through adapters such as Grb2 and SLP76
(20). Once recruited, Vav1 may trigger the Rac1→PAK1→
MEK→ERK cascade that elicits cytotoxicity in human NK
cells (13). In addition, Vav1 may facilitate formation of the
SLP76–PLC complex, PLC- activation and subsequent
Ca2 mobilization, as previously observed in T cells (15).
DAP12 and FcR trigger Syk and PI-3K (7), which represent the most likely mediators of Vav2 and Vav3 activation.
Moreover, Syk allows recruitment of the molecular adaptor
LAT (26), which can recruit PLC2 independently of
Vav1, possibly explaining why Vav1 is not critical for
DAP12 and FcR signaling.
Despite the different requirements for Vav proteins, both
DAP10 and DAP12 signaling pathways promoted ERK1/2
activation (Fig. 4 and references 7, 8, 11). ERK1/2 may be
an important link between Vavs and DAP10- and DAP12mediated cytotoxicity. Consistent with this, we showed
that deficiency of Vav proteins reduces ERK1/2 activation
and pharmacological inhibition of ERK1/2 activation reduces both DAP10- and DAP12-mediated cytotoxicities.
Whether Vav proteins differ in their capacity to recruit additional molecules linking DAP10 and ITAM with cytotoxicity, such as PLC (20, 27), remains to be determined.
It is also possible that ITAM→Vav2/Vav3 signaling differs
from DAP10→Vav1 signaling in strength and kinetics. The
former may be more sustained than the latter, allowing not
only for changes in actin cytoskeleton, polarization, and
exocytosis of cytotoxic granules, but also for transcriptional
activation of cytokine genes and cytokine secretion (28).
In agreement with this model, it has been shown that
NKG2D can trigger IFN- secretion only through DAP12,
not DAP10 (29) and that Vav1 is not required for NK
cell secretion of IFN- (21). It is not yet known whether
DAP12 and ITAMs require Vav2 and Vav3 to trigger IFN-
secretion.
Finally, our work illustrates a unique role for the Vav
proteins in NK cells in comparison to T and B cells. Although lack of Vav proteins leads to a profound impairment of T and B cell maturation and function (23), Vav
proteins are dispensable for NK cell development, but are
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role of defective adhesion in impairment of NK cell–mediated
lysis (Fig. S4, available at http://www.jem.org/cgi/content/
full/jem.20031847/DC1).
In summary, we investigated the contribution of Vav1,
Vav2, and Vav3 to NK cell cytotoxicity pathways triggered
by individual activating receptors. Our results demonstrate
that Vav1 is essential for DAP10-mediated cytotoxicity,
whereas Vav2 and Vav3 are required for FcR and DAP12
signaling. Consistent with this conclusion, lack of Vav1
drastically reduced NKG2D-L/DAP10-mediated cytotoxicity of tumor cells expressing NKG2D ligands, but had no
significant effect on ADCC and Ly49D/DAP12-, Ly49H/
DAP12-, and NKG2D-S/DAP12-mediated cytotoxicity.
In striking contrast, lack of both Vav2 and Vav3 abrogated
ADCC and substantially reduced Ly49H/DAP12- and
NKG2D-S/DAP12-mediated cytotoxicity. Because neither Vav2ko nor Vav3ko NK cells had obvious cytolitic defects, we suggest that there is functional redundancy between Vav2 and Vav3.
Early in vitro studies on human NK cells had indicated a
role for Vav1 in natural cytotoxicity against tumor cells and
ADCC (16, 17). Later in vivo studies using Vav1-deficient
mice confirmed that Vav1 is important for natural cytotoxicity (21, 22). However, they did not conclusively determine
whether Vav1 deficiency globally impairs NK cell–mediated cytotoxicity (21), or selectively affects natural cytotoxicity and maintains ADCC (22). Our observation that Vav1
is not required for ITAM-mediated cytotoxicity corroborates and extends the latter model. It has been proposed that
Vav1 may be a crucial target for inhibitory NK cell receptors to prevent NK cell activation and cytotoxicity (25).
Our data suggest that, although Vav1 dephosphorylation
might inhibit the NKG2D–DAP10-dependent pathway, it
would not be sufficient to block all NK cell–activating pathways. Previous studies showed that Vav2 is expressed in human NK cells and enhances their natural and FcRIIIamediated cytotoxicity (24). Our analysis of Vav2,3ko NK
cells confirms that Vav2 (and Vav3) performs an essential
function in ADCC and extends it to ITAM signaling.
We also analyzed Vav1,2,3ko mice and demonstrated that
lack of all three Vav proteins results in a profound reduction in NK cell–mediated cytotoxicity. However, we noted
one remarkable exception: Vav1,2,3ko NK cells can efficiently lyse CHO cells. NK cell recognition of CHO cells
is partially mediated by the Ly49D–DAP12 receptor complex, which binds the CHO class I molecule Hm1-C4 (4).
It is possible that, in contrast with Ly49H/DAP12 and
NKG2D-S/DAP12, Ly49D/DAP12 signaling is entirely
Vav independent. However, a more plausible explanation
is that NK cell recognition of CHO cells depends not only
on signals triggered by Ly49D/DAP12, but on multiple
signals transduced by distinct receptors, which integrate
and synergize to reach a critical activating threshold (8).
Some of these CHO cell–specific receptors may be Vav independent. Therefore, even if weakened by the absence of
all Vav proteins, residual Ly49D/DAP12 signaling may
reach the threshold required for cytotoxicity, if facilitated
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required for NK cell effector functions. This result suggests
a fundamental difference in function of the ITAM-containing signaling adapters, DAP12 and FcR in NK cells,
CD3 in T cells, and Ig and Ig in B cells.
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